Table 2.
Relative 1- and 5-year survival (% and 95%CI) in cancers of the oral cavity and pharynx in FI and SE men
| FI men 1-y | 1970–1979 | 1980–1989 | 1990–1999 | 2000–2009 | 2010–2019 |
| Oral Cavity | 69.6 [62.7–75.5] | 72.7 [67.1–77.4] | 77.2 [73.0–80.8] | 79.7 [76.6–82.5] | 79.0 [76.5–81.2] |
| Oropharynx | 61.4 [51.9–69.5] | 62.3 [54.1–69.4] | 60.9 [52.5–68.2] | 75.8*[69.9–80.7] | 78.1 [74.9–81.0] |
| Nasopharynx | 66.4 [50.6–78.2] | 74.4 [59.2–84.6] | 67.8 [54.3–78.0] | 73.8 [59.8–83.5] | 71.7 [57.4–81.9] |
| Hypopharynx | 47.1 [37.5–56.1] | 48.4 [39.0–57.1] | 58.0 [49.1–65.9] | 60.6 [53.1–67.3] | 59.9 [53.5–65.8] |
| SE men 1-y | 1970–1979 | 1980–1989 | 1990–1999 | 2000–2009 | 2010–2019 |
| Oral Cavity | 69.7 [66.6–72.5] | 71.1 [68.4–73.6] | 74.5 [71.9–76.8] | 73.5 [70.9–75.8] | 80.8*[78.8–82.6] |
| Oropharynx | 59.5 [54.0–64.5] | 62.2 [57.9–66.2] | 70.5*[66.7–74.0] | 77.0 [73.9–79.7] | 84.6*[82.7–86.4] |
| Nasopharynx | 67.6 [60.4–73.7] | 71.6 [64.8–77.4] | 82.4 [74.9–87.9] | 74.2 [64.9–81.4] | 88.4 [80.3–93.4] |
| Hypopharynx | 50.4 [45.3–55.3] | 50.6 [46.1–54.9] | 52.5 [47.7–57.0] | 53.8 [49.1–58.4] | 58.0 [52.4–63.1] |
| FI men 5-y | 1970–1979 | 1980–1989 | 1990–1999 | 2000–2009 | 2010–2019 |
| Oral cavity | 38.7 [30.2–47.2] | 41.2 [34.4–47.9] | 48.4 [42.9–53.7] | 55.9 [51.6–60.0] | 61.2 [57.3–64.8] |
| Oropharynx | 32.2 [22.7–42.0] | 23.0 [16.3–30.5] | 33.3 [25.1–41.6] | 47.1 [40.4–53.5] | 59.1*[54.3–63.6] |
| Nasopharynx | 35.0 [21.5–48.8] | 46.1 [29.4–61.3] | 36.8 [23.4–50.2] | 51.0 [35.7–64.4] | 49.9 [33.8–64.1] |
| Hypopharynx | 11.8 [5.7–20.3] | 10.8 [5.6–17.9] | 17.2 [10.6–25.1] | 26.0 [19.4–33.0] | 25.7 [19.2–32.6] |
| SE men 5-y | 1970–1979 | 1980–1989 | 1990–1999 | 2000–2009 | 2010–2019 |
| Oral cavity | 45.5 [41.6–49.4] | 41.4 [38.1–44.6] | 48.7*[45.4–52.0] | 51.0 [47.8–54.1] | 61.8*[58.7–64.8] |
| Oropharynx | 24.3 [19.2–29.7] | 31.1 [26.7–35.6] | 41.6*[37.2–45.9] | 53.8*[50.0–57.4] | 66.2*[63.2–69.1] |
| Nasopharynx | 33.9 [26.6–41.4] | 39.6 [32.3–46.8] | 48.9 [38.9–58.1] | 43.4 [33.5–52.9] | 61.8 [49.9–71.7] |
| Hypopharynx | 12.2 [8.8–16.0] | 18.5 [14.9–22.4] | 19.1 [15.4–23.1] | 20.0 [16.1–24.2] | 22.3 [17.2–27.8] |
Bolding: Survival significantly increased between last and first period. *Survival significantly increased between the periods. Underlining: Significant country difference